1 recruiting, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Recruiting 1, Withdrawn 1 |
Follow Multiple Myeloma Refractory: new trials by email Literature Review of Multiple Myeloma Refractory trials Research Report on Multiple Myeloma Refractory
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BCMA/GPRC5D CAR-T Therapy for Multiple Myeloma BCMA/GPRC5D CAR-T - Multiple Myeloma Refractory | Early Phase 1 | Withdrawn | Guangzhou Bio-gene Technology Co., Ltd | 2025-10-10 | 2026-05-28 | |
| A Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM) Soursop tea - AML (Acute Myeloid Leukemia), Multiple Myeloma Refractory | Early Phase 1 | Recruiting | Roger Strair | 20 | 2025-06-30 | 2026-08-18 |
Leukemia, Myeloid, Acute (1) · Recurrence (1)
Disease Attributes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Guangzhou Bio-gene Technology Co., Ltd (1) · Roger Strair (1)
United States (1)
Roger Strair, MD (1)